Literature DB >> 23526067

Adjustable intragastric balloon vs non-adjustable intragastric balloon: case-control study on complications, tolerance, and efficacy.

Alfredo Genco1, Daniela Dellepiane, Giovanni Baglio, Fulvio Cappelletti, Francesca Frangella, Roberta Maselli, Maria Chiara Dante, Romina Camoirano, Michele Lorenzo, Nicola Basso.   

Abstract

BACKGROUND: The objective of this study is the comparison of a new intragastric balloon recently introduced, the Adjustable Balloon System (ABS), with the BioEnterics intragastric balloon (BIB) in terms of tolerance, safety, and weight loss parameters.
METHODS: A case-control study was done: 40 patients were matched with 80 controls. To achieve the same duration therapy (12 months), a single ABS positioning was compared with a BIB followed by another BIB (6 + 6 months). Length of procedure, hospital stay, complications, and weight loss parameters after 6 months (time of first BIB removal) and after 12 months from baseline (time of Spatz and second BIB removal) were considered. Statistical analysis was done by means of Student's t test, χ2 test, or Fisher's test. P < 0.05 was considered significant.
RESULTS: Mortality, positioning, and extraction complications were absent. Both the devices were well tolerated with slight duration of post placement symptoms. During this study, the Spatz balloon was adjusted with inflation of 200 cm(3) of saline (total, 800 cm(3)) in 9/40 (22.5 %) patients, for poor weight loss after first 6-months treatment. In the Spatz group, there occurred 7/40 complications linked to the device and in 6/7 patients the balloon was removed. At the end of the study, the weight loss parameters were similar between groups: BMI 31.0 ± 11.8 (Spatz group) vs 31.3 ± 12.3 (BIB group) (p = Ns).
CONCLUSIONS: The idea of dynamic balloon therapy needs to be confirmed with wider series. The rate of complication reported is very high, and several studies regarding safety and efficacy are needed.

Entities:  

Mesh:

Year:  2013        PMID: 23526067     DOI: 10.1007/s11695-013-0891-5

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  19 in total

Review 1.  Evidence-based review of the Bioenterics intragastric balloon for weight loss.

Authors:  Jean-Marc Dumonceau
Journal:  Obes Surg       Date:  2008-06-21       Impact factor: 4.129

Review 2.  NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel.

Authors: 
Journal:  Ann Intern Med       Date:  1991-12-15       Impact factor: 25.391

3.  BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients.

Authors:  A Genco; M Cipriano; V Bacci; M Cuzzolaro; A Materia; L Raparelli; C Docimo; M Lorenzo; N Basso
Journal:  Int J Obes (Lond)       Date:  2006-01       Impact factor: 5.095

4.  Obesity and the gastric balloon: a comprehensive workshop. Tarpon Springs, Florida, March 19-21, 1987.

Authors:  M Schapiro; S Benjamin; G Blackburn; B Frank; D Heber; R Kozarek; S Randall; W Stern
Journal:  Gastrointest Endosc       Date:  1987-08       Impact factor: 9.427

5.  Intragastric balloon for high-risk super-obese patients: a prospective analysis of efficacy.

Authors:  Charalambos Spyropoulos; Evaggelos Katsakoulis; Nancy Mead; Konstantinos Vagenas; Fotis Kalfarentzos
Journal:  Surg Obes Relat Dis       Date:  2007 Jan-Feb       Impact factor: 4.734

6.  Is bariatric surgery necessary after intragastric balloon treatment?

Authors:  Luigi Angrisani; Michele Lorenzo; Vincenzo Borrelli; Monica Giuffré; Carmine Fonderico; Giuseppe Capece
Journal:  Obes Surg       Date:  2006-09       Impact factor: 4.129

7.  Intragastric balloons for preoperative weight reduction.

Authors:  B De Waele; H Reynaert; D Urbain; G Willems
Journal:  Obes Surg       Date:  2000-02       Impact factor: 4.129

8.  BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients.

Authors:  A Genco; T Bruni; S B Doldi; P Forestieri; M Marino; L Busetto; C Giardiello; L Angrisani; L Pecchioli; P Stornelli; F Puglisi; M Alkilani; A Nigri; N Di Lorenzo; F Furbetta; A Cascardo; M Cipriano; M Lorenzo; N Basso
Journal:  Obes Surg       Date:  2005-09       Impact factor: 4.129

9.  BioEnterics® intragastric balloon (BIB®). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons.

Authors:  Gontrand Lopez-Nava; Miguel Angel Rubio; Susana Prados; Gabriela Pastor; Mar Rodriguez Cruz; Ena Companioni; Andres Lopez
Journal:  Obes Surg       Date:  2010-03-20       Impact factor: 4.129

10.  Intragastric balloon or diet alone? A retrospective evaluation.

Authors:  Alfredo Genco; Stefano Balducci; Vincenzo Bacci; Alberto Materia; Massimiliano Cipriano; Giovanni Baglio; Maria Cristina Ribaudo; Roberta Maselli; Michele Lorenzo; Nicola Basso
Journal:  Obes Surg       Date:  2008-05-16       Impact factor: 4.129

View more
  19 in total

1.  One-year adjustable intragastric balloons: do they offer more than two consecutive nonadjustable 6-month balloons? A response to Genco et al.

Authors:  Jeffrey Brooks
Journal:  Obes Surg       Date:  2013-12       Impact factor: 4.129

Review 2.  Filling the Void: A Review of Intragastric Balloons for Obesity.

Authors:  Patrick Laing; Tuan Pham; Linda Jo Taylor; John Fang
Journal:  Dig Dis Sci       Date:  2017-04-18       Impact factor: 3.199

Review 3.  Development of minimally invasive techniques for management of medically-complicated obesity.

Authors:  Farzin Rashti; Ekta Gupta; Suzan Ebrahimi; Timothy R Shope; Timothy R Koch; Christopher J Gostout
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 4.  Current status of intragastric balloon for obesity treatment.

Authors:  Seung Han Kim; Hoon Jai Chun; Hyuk Soon Choi; Eun Sun Kim; Bora Keum; Yoon Tae Jeen
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

5.  One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K.

Authors:  J Brooks; E D Srivastava; E M H Mathus-Vliegen
Journal:  Obes Surg       Date:  2014-05       Impact factor: 4.129

6.  Fluid-Filled Versus Gas-Filled Intragastric Balloons as Obesity Interventions: a Network Meta-analysis of Randomized Trials.

Authors:  Fateh Bazerbachi; Samir Haffar; Tarek Sawas; Eric J Vargas; Ravinder Jeet Kaur; Zhen Wang; Larry J Prokop; M Hassan Murad; Barham K Abu Dayyeh
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

7.  Silicone rubber encapsulation for an endoscopically implantable gastrostimulator.

Authors:  Laurent Lonys; Anne Vanhoestenberghe; Nicolas Julémont; Stéphane Godet; Marie-Paule Delplancke; Pierre Mathys; Antoine Nonclercq
Journal:  Med Biol Eng Comput       Date:  2015-01-06       Impact factor: 2.602

8.  Intragastric balloon for obesity treatment: results of a multicentric evaluation for balloons left in place for more than 6 months.

Authors:  Alfredo Genco; Roberta Maselli; Francesca Frangella; Massimiliano Cipriano; Pietro Forestieri; Daniela Delle Piane; Francesco Furbetta; Giancarlo Micheletto; Franco Ciampaglia; Paola Granelli; Maurizio Zilli; Michele Lorenzo; Giorgio Di Rocco; Domenico Giannotti; Adriano Redler
Journal:  Surg Endosc       Date:  2014-12-06       Impact factor: 4.584

9.  Elipse™, a Procedureless Gastric Balloon for Weight Loss: a Proof-of-Concept Pilot Study.

Authors:  Evzen Machytka; Ram Chuttani; Martina Bojkova; Tomas Kupka; Marek Buzga; Kathryn Stecco; Samuel Levy; Shantanu Gaur
Journal:  Obes Surg       Date:  2016-03       Impact factor: 4.129

10.  Randomized Prospective Clinical Study of Spatz3® Adjustable Intragastric Balloon Treatment with a Control Group: a Large-Scale Brazilian Experiment.

Authors:  Ricardo José Fittipaldi-Fernandez; Idiberto José Zotarelli-Filho; Cristina Fajardo Diestel; Márcia Regina Simas Torres Klein; Marcelo Falcão de Santana; João Henrique Felicio de Lima; Fernando Santos Silva Bastos; Newton Teixeira Dos Santos
Journal:  Obes Surg       Date:  2020-10-01       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.